secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001437749-25-006764
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia granted Japanese patent for Helix biotherapeutic delivery catheter expiring 2034
--------------------------------------------------------------------------------

- Japan Patent Office issued Patent No. 7641330 titled 'Radial and Transendocardial Delivery Catheter'.
- Patent term expires on or after September 30, 2034; covers helical needle-tipped catheter platform.
- BioCardia CEO cites growing IP position for cell/gene therapy delivery; Japan is important initial market.
- Helix System is the only catheter-based intramyocardial delivery system in active clinical use per BioCardia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925006764/0001437749-25-006764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925006764/bcda20250308_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-006764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer